-
-
-
-
-
-
-
Celcuity (CELC) Reiterated at Buy by Stifel on Revtorpyk Approval
-
-
-
-
-
-
-
FDA accepts Bristol Myers Squibb's mezigdomide application for myeloma
-
-
-
-
-
-
-
FDA grants priority review to Agios' mitapivat for sickle cell disease
-
-
-
-
-
-
-
FDA extends review of Praxis drug for rare epilepsy to December 2026
-
-
-
-
-
-
-
Moderna (MRNA) PT Raised to $77 at Piper Sandler
-
-
-
-
-
-
-
Ionis licenses zilganersen to Recordati for ex-U.S. markets
-
-
-
-
-
-
-
FDA accepts OUTLOOK THERAPEUTICS BLA resubmission for wet AMD drug
-
15,554 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

